Scynexis up on beating Q2 earnings

Scynexis

15/08/2023 12:42

** SCYNEXIS shares  SCYX.O  rise 17.1% to $3.3 before the
bell
    ** Biotech firm reported Q2 revenue of $131.5 million
compared to analysts' estimates of $95.45 mln - Refinitiv data
    ** Co said the revenue increase during the quarter was
driven by the licensing agreement from GSK  GSK.L 
    ** Q2 adj. profit was $2.45/share vs estimates of
$1.55/share
     ** Co's cash, cash equivalents totaled $91.9 mln on June
30, 2023, compared to $73.5 mln on Dec 31, 2022
    ** Up to Monday's close, stock had risen ~79% YTD

 (Reporting by Khushi Mandowara in Bengaluru)
 ((Khushi.Mandowara@thomsonreuters.com;))